Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,587.60
(
1.31%
)
Dow Jones
45,577.47
(
0.00%
)
Brent Oil
100.49
(
-7.07%
)
Bitcoin
70,260.88
(
3.57%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: JustGoLong post# 121301

Wednesday, 06/08/2011 5:15:32 PM

Wednesday, June 08, 2011 5:15:32 PM

Post# of 257269

Is that a valid reason not to approve a drug?

It could be.

Put yourself in the shoes of an FDA reviewer. Why would you take a chance on approving a newfangled cell-based therapy for a cosmetic indication when there are several biologically inert dermal fillers on the market for the same indication that are effective and very safe?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today